|
GGA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.26209999998339E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.15469994571771E-09 |
| Normal-vs-Stage2 |
1.196840E-01 |
| Normal-vs-Stage3 |
5.990800E-01 |
| Normal-vs-Stage4 |
1.548190E-01 |
| Stage1-vs-Stage2 |
6.572300E-02 |
| Stage1-vs-Stage3 |
4.543500E-02 |
| Stage1-vs-Stage4 |
3.777400E-01 |
| Stage2-vs-Stage3 |
5.487400E-01 |
| Stage2-vs-Stage4 |
7.282800E-01 |
| Stage3-vs-Stage4 |
4.688600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.1512999999771E-06 |
| Normal-vs-AfricanAmerican |
3.201800E-04 |
| Normal-vs-Asian |
5.284600E-01 |
| Caucasian-vs-AfricanAmerican |
6.764000E-01 |
| Caucasian-vs-Asian |
5.477600E-01 |
| AfricanAmerican-vs-Asian |
4.893800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59119999999513E-05 |
| Normal-vs-Female |
4.179200E-04 |
| Male-vs-Female |
6.764800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.897400E-03 |
| Normal-vs-Extreme_Weight |
1.07069999977227E-07 |
| Normal-vs-Obese |
7.043300E-03 |
| Normal-vs-Extreme_Obese |
3.313800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.922400E-01 |
| Normal_Weight-vs-Obese |
4.258200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.280000E-01 |
| Extreme_Weight-vs-Obese |
6.983600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.595700E-02 |
| Obese-vs-Extreme_Obese |
6.923400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.301600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.208500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.28239999996893E-06 |
| Normal-vs-Age(81-100Yrs) |
1.942120E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.992600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.308400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.328600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.432800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.171600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.203200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.04399999756311E-08 |
| Normal-VS-Type2 PRCC |
1.193020E-01 |
| Normal-VS-KIRP CIMP |
4.122400E-02 |
| Normal-VS-Unclassified PRCC |
7.197200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.411660E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.301600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.917800E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.505000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.466000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.477240E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.421700E-02 |
| Normal-vs-N1 |
6.615200E-01 |
| Normal-vs-N2 |
3.949000E-01 |
| N0-vs-N1 |
3.135200E-01 |
| N0-vs-N2 |
9.490800E-01 |
| N1-vs-N2 |
6.144200E-01 |
|
|
